Scholarlink

<p>Conventional molecular diagnostics for imprinting disorders rely on sequential DNA-intensive assays, which are expensive, time-consuming, and often insufficient for detecting mosaicism, resulting in suboptimal clinical management. Here, we present a targeted long-read sequencing strategy that enables the integrated detection of DNA methylation, copy-number variants, and sequence variants in a single assay for Beckwith-Wiedemann spectrum (BWSp), a genomic imprinting disorder caused by genetic or epigenetic alterations affecting imprinting control regions 1 and 2 (IC1/IC2) within the 11p15.5 locus. We evaluated three Oxford Nanopore Technologies (ONT) workflows: adaptive sampling on MinION (AS-MinION), adaptive sampling on PromethION P2 (AS-P2), and whole-genome sequencing on P2 (WGS-P2). Three cases of BWSp patients were analyzed, including two with mosaic paternal uniparental disomy (pUPD) and one with IC2 loss of methylation (LoM). We compared sequencing output, genome-wide and region-of-interest coverage, IC1/IC2 methylation profiles, and variant concordance with Illumina short read sequencing using the Simplex basecalling model. AS-P2 achieved the highest coverage of target regions while maintaining broad and uniform genome-wide coverage, outperforming AS-MinION and WGS-P2. This dual performance enables efficient and scalable simultaneous genetic and epigenetic analysis in a single sequencing run. Using Simplex basecalling, AS-P2 accurately identified all underlying molecular defects in conventionally characterized samples. In conclusion, AS-P2 enablesa cost-effective and sensitive approach for the molecular diagnosis of imprinting disorders, particularly in cases with mosaic or complex genetic and epigenetic architectures.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Targeted long-read sequencing with adaptive sampling enables the integrated genomic and epigenomic profiling of imprinting disorders

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月4日

查看全文
  • Federico Rondot,
  • Federica Centofanti,
  • Anna Micaletto,
  • Luca Angheben,
  • Federico Fontana,
  • Niccolò Rossi,
  • Flavia Cerrato,
  • Laura Pignata,
  • Giada Carta,
  • Silvia Di Tommaso,
  • Piera Bontempo,
  • Barbara Pasini,
  • Antonio Novelli,
  • Alessandro Mussa,
  • Andrea Riccio,
  • Giovanni Battista Ferrero,
  • Alfredo Brusco,
  • Massimo Delledonne

摘要

Conventional molecular diagnostics for imprinting disorders rely on sequential DNA-intensive assays, which are expensive, time-consuming, and often insufficient for detecting mosaicism, resulting in suboptimal clinical management. Here, we present a targeted long-read sequencing strategy that enables the integrated detection of DNA methylation, copy-number variants, and sequence variants in a single assay for Beckwith-Wiedemann spectrum (BWSp), a genomic imprinting disorder caused by genetic or epigenetic alterations affecting imprinting control regions 1 and 2 (IC1/IC2) within the 11p15.5 locus. We evaluated three Oxford Nanopore Technologies (ONT) workflows: adaptive sampling on MinION (AS-MinION), adaptive sampling on PromethION P2 (AS-P2), and whole-genome sequencing on P2 (WGS-P2). Three cases of BWSp patients were analyzed, including two with mosaic paternal uniparental disomy (pUPD) and one with IC2 loss of methylation (LoM). We compared sequencing output, genome-wide and region-of-interest coverage, IC1/IC2 methylation profiles, and variant concordance with Illumina short read sequencing using the Simplex basecalling model. AS-P2 achieved the highest coverage of target regions while maintaining broad and uniform genome-wide coverage, outperforming AS-MinION and WGS-P2. This dual performance enables efficient and scalable simultaneous genetic and epigenetic analysis in a single sequencing run. Using Simplex basecalling, AS-P2 accurately identified all underlying molecular defects in conventionally characterized samples. In conclusion, AS-P2 enablesa cost-effective and sensitive approach for the molecular diagnosis of imprinting disorders, particularly in cases with mosaic or complex genetic and epigenetic architectures.